<?xml version="1.0" encoding="UTF-8"?>
<EXPERIMENT_SET xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
		xsi:noNamespaceSchemaLocation="ftp://ftp.sra.ebi.ac.uk/meta/xsd/sra_1_5/SRA.experiment.xsd">
  <EXPERIMENT alias="TODO: UNIQUE NAME FOR EXPERIMENT" center_name="TODO: ACCOUNT CENTER_NAME">
    <TITLE>TODO: TITLE OF EXPERIMENT</TITLE>
    <STUDY_REF refname="TODO: STUDY ALIAS OF RELEVANT STUDY OBJECT"/>
    <DESIGN>
      <DESIGN_DESCRIPTION>TODO: DETAILS ABOUT THE SETUP AND GOALS OF THE EXPERIMENT AS SUPPLIED BY INVESTIGATOR</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR refname="TODO: SAMPLE ALIAS OF RELEVANT SAMPLE OBJECT"/>
      <LIBRARY_DESCRIPTOR>
	<LIBRARY_NAME>TODO: NAME OF LIBRARY</LIBRARY_NAME>
	<LIBRARY_STRATEGY>TODO: CHOOSE FROM CONTROLLED VOCABULARY AT END OF XML</LIBRARY_STRATEGY>
	<LIBRARY_SOURCE>TODO: CHOOSE FROM CONTROLLED VOCABULARY AT END OF XML </LIBRARY_SOURCE>
	<LIBRARY_SELECTION>TODO: CHOOSE FROM CONTROLLED VOCABULARY AT END OF XML </LIBRARY_SELECTION>
	<LIBRARY_LAYOUT>
	  <PAIRED/> <!-- The element accepted under the LIBRARY_LAYOUT is either <PAIRED/> or <SINGLE/> -->
	</LIBRARY_LAYOUT>	  
	<LIBRARY_CONSTRUCTION_PROTOCOL>TODO: PROTOCOL BY WHICH THE LIBRARY WAS CONSTRUCTED</LIBRARY_CONSTRUCTION_PROTOCOL>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <ILLUMINA>
	<INSTRUMENT_MODEL>TODO: CHOOSE FROM CONTROLLED VOCABULARY AT END OF XML </INSTRUMENT_MODEL>
      </ILLUMINA>
    </PLATFORM>
    <PROCESSING/>
  </EXPERIMENT> <!-- If you are submitting more than one experiment, replicate the block <EXPERIMENT> to </EXPERIMENT> here, as many times as necessary. -->
</EXPERIMENT_SET>
     <!-- Controlled vocabulary for LIBRARY_LAYOUT
          SINGLE
          PAIRED
     -->
     <!-- Controlled vocabulary for PLATFORM
          LS454
          ILLUMINA
          COMPLETE_GENOMICS
          PACBIO_SMRT
          ION_TORRENT
          OXFORD_NANOPORE
          CAPILLARY
     -->
     <!--Controlled vocabulary for LS454 INSTRUMENT_MODEL:
         454 GS
         454 GS 20454 GS FLX
         454 GS FLX+
         454 GS FLX Titanium
         454 GS Junior
         unspecified
     -->
     <!-- Controlled vocabulary for ILLUMINA INSTRUMENT_MODEL:
          Illumina Genome Analyzer
          Illumina Genome Analyzer II
          Illumina Genome Analyzer IIx
          Illumina HiSeq 2500
          Illumina HiSeq 2000
          Illumina HiSeq 1500
          Illumina HiSeq 1000
          Illumina MiSeq
          Illumina HiScanSQ
          HiSeq X Ten
          NextSeq 500
          unspecified
     -->
     <!-- Controlled vocabulary for COMPLETE_GENOMICS INSTRUMENT_MODEL:
          Complete Genomics
          unspecified
     -->
     <!-- Controlled vocabulary for PACBIO_SMRT INSTRUMENT_MODEL:
          PacBio RS
          PacBio RS II
          unspecified
     -->
     <!-- Controlled vocabulary for ION_TORRENT INSTRUMENT_MODEL:
          Ion Torrent PGM
          Ion Torrent Proton
          unspecified
     -->
     <!-- Controlled vocabulary for OXFORD_NANOPORE INSTRUMENT_MODEL:
          MinION
          GridION
          unspecified
     -->
     <!-- Controlled vocabulary for CAPILLARY INSTRUMENT_MODEL:
          AB 3730xL Genetic Analyzer
          AB 3730 Genetic Analyzer
          AB 3500xL Genetic Analyzer
          AB 3500 Genetic Analyzer
          AB 3130xL Genetic Analyzer
          AB 3130 Genetic Analyzer
          AB 310 Genetic Analyzer
     -->
     <!-- Controlled vocabulary for LIBRARY STRATEGY (description in parentheses):
          WGS (Random sequencing of the whole genome)
          WGA (whole genome amplification to replace some instances of RANDOM)
          WXS (Random sequencing of exonic regions selected from the genome)
          RNA-Seq (Random sequencing of whole transcriptome)
          miRNA-Seq (for micro RNA and other small non-coding RNA sequencing)
          ncRNA-Seq(Non-coding RNA)
          WCS (Random sequencing of a whole chromosome or other replicon isolated
          from a genome)
          CLONE (Genomic clone based (hierarchical) sequencing)
          POOLCLONE (Shotgun of pooled clones (usually BACs and Fosmids))
          AMPLICON (Sequencing of overlapping or distinct PCR or RT-PCR products)
          CLONEEND (Clone end (5', 3', or both) sequencing)
          FINISHING (Sequencing intended to finish (close) gaps in existing coverage)
          ChIP-Seq (Direct sequencing of chromatin immunoprecipitates)
          MNase-Seq (Direct sequencing following MNase digestion)
          DNase-Hypersensitivity (Sequencing of hypersensitive sites, or segments of
          open chromatin that are more readily cleaved by DNaseI)
          Bisulfite-Seq (Sequencing following treatment of DNA with bisulfite to
          convert cytosine residues to uracil depending on methylation status)
          EST (Single pass sequencing of cDNA templates)
          FL-cDNA (Full-length sequencing of cDNA templates)
          CTS (Concatenated Tag Sequencing)
          MRE-Seq (Methylation-Sensitive Restriction Enzyme Sequencing strategy)
          MeDIP-Seq (Methylated DNA Immunoprecipitation Sequencing strategy)
          MBD-Seq (Direct sequencing of methylated fractions sequencing strategy)
          Tn-Seq (for gene fitness determination through transposon seeding)
          VALIDATION (CGHub special request: Independent experiment to re-evaluate putative variants.
          Micro RNA sequencing strategy designed to capturepost-transcriptional RNA elements and include non-coding functional elements)
          FAIRE-seq (Formaldehyde-Assisted Isolation of Regulatory Elements)
          SELEX (Systematic Evolution of Ligands by EXponential enrichment (SELEX) is an
          in vitro strategy to analyze RNA sequences that perform an activity of interest, most
          commonly high affinity binding to a ligand)
          RIP-Seq (Direct sequencing of RNA immunoprecipitates (includes CLIP-Seq, HITS-CLIP and PAR-CLI))
          ChiA-PET (Direct sequencing of proximity-ligated chromatin immunoprecipitates)
          RAD-Seq (Restriction site Associated DNA Sequencing is a method for sampling the genomes of multiple individuals in a population
          using NGS)
          OTHER (Library strategy not listed)
     -->
     <!-- Controlled vocabulary for LIBRARY SOURCE (description in parentheses):
          GENOMIC (Genomic DNA (includes PCR products from genomic DNA))
          TRANSCRIPTOMIC (Transcription products or non genomic DNA (EST, cDNA, RT-PCR,
          screened libraries))
          METAGENOMIC (Mixed material from metagenome)
          METATRANSCRIPTOMIC (Transcription products from community targets)
          SYNTHETIC (Synthetic DNA)
          VIRAL RNA (Viral RNA)
          OTHER (Other, unspecified, or unknown library source material)
     -->
     <!-- Controlled vocabulary for LIBRARY SELECTION (description in parentheses):
          RANDOM (Random selection by shearing or other method)
          PCR (Source material was selected by designed primers)
          RANDOM PCR (Source material was selected by randomly generated primers)
          RT-PCR (Source material was selected by reverse transcription PCR)
          HMPR (Hypo-methylated partial restriction digest)
          MF (Methyl Filtrated)
          repeat fractionation (replaces: CF-S, CF-M, CF-H, CF-T)
          size fractionation
          MSLL (Methylation Spanning Linking Library)
          cDNA (complementary DNA)
          ChIP (Chromatin immunoprecipitation)
          MNase (Micrococcal Nuclease (MNase) digestion)
          DNase (Deoxyribonuclease (MNase) digestion)
          Hybrid Selection (Selection by hybridization in array or solution)
          Reduced Representation (Reproducible genomic subsets, often generated by
          restriction fragment size selection, containing a
          manageable number of loci to facilitate re-sampling)
          Restriction Digest (DNA fractionation using restriction enzymes)
          5-methylcytidine antibody (Selection of methylated DNA fragments using an
          antibody raised against 5-methylcytosine or
          5-methylcytidine (m5C))
          MBD2 protein methyl-CpG binding domain (Enrichment by methyl-CpG binding domain)
          CAGE (Cap-analysis gene expression)
          RACE (Rapid Amplification of cDNA Ends)
          MDA (Multiple displacement amplification)
          padlock probes capture method (to be used in conjuction with Bisulfite-Seq)
          Inverse rRNA selection (Remove the ribosomal transcripts by inverse selection: you capture them by annealing with specific oligos,
          also bound to beads, and then discard that)
          Oligo-dT (Select primarily messenger RNA, which conveniently is polyadenylated so these transcripts can be captured with oligo-dT beads)
          other (Other library enrichment, screening, or selection process)
          unspecified (Library enrichment, screening, or selection is not specified)
     -->
